Afya (AFYA) Earnings Analysis
Afya (AFYA) next reports earnings on 2026-08-12, consensus EPS 0.4008 USD. Last quarter (2026-05-07) it beat with EPS 0.56 USD vs 0.53 USD est (+5.7%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 8.38.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AFYA next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | 0.4008 USD |
| Revenue estimate | 0.19B |
AFYA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.56 USD | 0.53 USD | +5.7% | Beat |
| 2026-03-12 | 0.41 USD | 0.38 USD | +7.9% | Beat |
| 2025-11-12 | 0.38 USD | 0.32 USD | +18.8% | Beat |
| 2025-08-13 | 0.4 USD | 0.4 USD | 0% | Beat |
| 2025-05-08 | 0.55 USD | 0.46 USD | +19.6% | Beat |
| 2025-03-13 | 0.36 USD | 0.34 USD | +5.9% | Beat |
| 2024-08-15 | 0.44 USD | 0.37 USD | +18.9% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
AFYA valuation and analyst view
| Trailing P/E | 8.38 |
|---|---|
| Trailing EPS | 8.451 USD |
| Price / book | 1.34 |
| Dividend yield | 4.73% |
| Market cap | 1.23B |
| Analyst consensus | Hold (3 buy / 4 hold / 1 sell) |
| Avg price target | 17.25 USD |
Related research pages
Frequently asked questions
When is Afya (AFYA)'s next earnings date?
Afya is next scheduled to report on 2026-08-12, with a consensus EPS estimate of 0.4008 USD and revenue estimate of 0.19B.
Did AFYA beat earnings last quarter?
In its 2026-05-07 report, AFYA posted EPS of 0.56 USD versus a 0.53 USD estimate — a beat of 5.7%.
What is AFYA's earnings track record?
Over the last 7 reported quarters with consensus data, AFYA beat estimates 7 times (100%).
What is AFYA's current P/E ratio and EPS?
AFYA trades at a trailing P/E of 8.38 on trailing EPS of 8.451159610430707 USD.
What do analysts rate AFYA?
Analyst consensus is "Hold" across 8 ratings (0 strong buy, 3 buy, 4 hold, 1 sell, 0 strong sell). Average 12-month price target: 17.25 USD.